[1] |
ZHU Li, WEI Bing, LIAO Shi'e, ZHANG Chao, ZHENG Xiaoyu, LIU Yajun.
Effects of single nucleotide polymorphism of drug metabolizing enzyme cytochrome P450 on the efficacy of inhaled cortisol hormone in asthmatic children
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 536-543.
|
[2] |
YAO Qian, CHEN Yun, SHANG Juan, XI Xiaoyun, CHEN Ying, GU Xiao, JU Wenzheng, ZOU Jiandong, LU Su, XU Meijuan.
Investigation of potential pharmacodynamic substances and mechanism of Qingxin-zishen prescription decoction in treatment of menopause syndrome based on HPLC-Q-TOF-MS/MS and network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 481-497.
|
[3] |
GUO Lu, ZHONG Zhendong, HAN Yicen, SHI Yi, YANG Yong, BIAN Yuan, LIU Xiaoshu, ZHANG Jing, LANG Qin, ZHONG Tian.
Effects of different administration methods on the pharmacokinetics and tissue distribution of ribavirin in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 25-32.
|
[4] |
CAI Mingmin, SHAO Jing, TANG Lu, SUN Qiuyue, DOU Ting, QIAN Wei, WANG Huiping.
Bioequivalence study of buthlphthalide injection in Chinese healthy volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 70-76.
|
[5] |
WU Yi, FANG Fang, CHEN Ying, Fan Junwei.
Influence of donor and recipient CYP3A5 genotype on tacrolimus trough concentrations in the early stage after liver transplantation and its clinical significance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 631-639.
|
[6] |
XU Guofang, ZHANG Sisen, LIU Ping, MEI Jiazhuan, LIU Weiwei, LIU Ya'ou, QI Qi.
Population pharmacokinetics of capecitabine in Chinese breast cancer patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 552-559.
|
[7] |
LIU Chang, DENG Kunhong, HUANG Jie, YANG Shuang, YANG Xiaoyan, XIANG Yuxia, HUANG Lu, ZHANG Zeyu, LIANG Wenzhong, LAN Jing, YANG Guoping.
Bioequivalence of moxifloxacin hydrochloride tablets in healthy Chinese subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1393-1399.
|
[8] |
YU Tianyi, JIAO Guangyang, HUANG Doudou, CHEN Yong, XU Deduo, QIU Shi, CHEN Wansheng, ZHANG Feng, WANG Bolong.
Analysis of the effective components and mechanism of Yufang Fangji II for prevention of COVID-19 based on UHPLC-Q-TOF/MS and network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1127-1145.
|
[9] |
WU Qiaoyu, YUAN Hong, LU Yao.
Evaluation of the effects of resveratrol on the activity human cytochrome P450 through combined probe method
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 426-432.
|
[10] |
WU Maofeng, LIU Chang, DAI Huihui, MAI Zhangfeng, HUANG Danli, MIAO Jingwei, LIU Lizhong, FANG Yi.
Preliminary association of individual different plasma pazopanib concentration with CYP3A4 gene polymorphism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1376-1380.
|
[11] |
CHEN Aiying, CHENG Min, MIAO Yunping, YE Xiaodi, TIAN Xuejun, ZHENG Gaoli.
Pharmacokinetics and tissue distribution characteristics of sunitinib#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(10): 1105-1110.
|
[12] |
XU Yichao, LOU Honggang, RUAN Zourong, CHEN Jinliang, JIANG Bo, SHAO Rong, YANG Dandan.
Bioequivalence of bosentan tablets in healthy Chinese volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 675-680.
|
[13] |
WANG Mengyao,HUANG Jie, LIU Yanan, YANG Shuang, WU Shuting, YANG Xiaoyan, YE Ling, GUO Can, HUANG Zhijun.
Study on bioequivalence of gefitinib tablets in healthy Chinese subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1275-1280.
|
[14] |
PENG Qiuju, YAN Huacheng, SHI Lei.
Advances in the relationship between cytochrome P450 SNP and susceptibility to coronary heart disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 477-480.
|
[15] |
ZHANG Peiyu, REN Jing, ZHI Wenqian, LIU Chengming, GAO Na.
Inhibition of CYP450 activity by honokiol and other four components of Chinese traditionalmedicine in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 922-926.
|